Amin Sharifan, PharmD

Abdulazeem, H.; Borges do Nascimento, I.J.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Cunningham, C.; Kularathne, I.; Deeken, G.; de Barros, J.; Sathian, B.; Østengaard, L.; Lamontagne-Godwin, F.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Alistair Dos Santos, R.; Azzopardi-Muscat, N.; Yon, Y.; Novillo-Ortiz, D. (2025). Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report. JMIR Ment Health, 12:e64445: 10.2196/64445

Feigin, V. L. ; Vos, T.; Nair, B. S.; Hay, S. I.; Abate, Y. H.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, 10: e203-27

GBD 2021 Europe Life Expectancy Collaborators; Steel, N., Sharifan, A. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health, 10: e172–88

GBD 2021 Suicide Collaborators; Davis Weaver, N.; Sharifan, A.; (2025). Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 10: e189-e202

Kerr, J. A.; Patton, G. C.; Cini, K. I.; Abate, Y. H.; Abbas, N.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 785-812

Li, S.; Zhang, L.; Wang, Y.; Xie, R.; Chen, W.; Soo Lee, M.; Amer, Y.S.; Sharifan, A.; Hussein, H.; Li, H. (2025). Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Frontiers in Pharmacology, 16:1501634: 10.3389/fphar.2025.1501634

M. Ng,; E. Gakidou,; J. Lo,; Y. H. Abate,; C. Abbafati,; N. Abbas,; et al. (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 813-38

Oh, J.; Kim, S.; Kim, M. S.; Abate, Y. H.; Abd ElHafeez, S.; Abdelkader, A.; et al. (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13, 5: 425-446

S. Lee, Y. Son, J. Hwang, M. S. Kim, J. I. Shin, N. J. Kassebaum, et al. (2025). Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine, https://doi.org/10.1038/s41591-025-03624-8: https://doi.org/10.1038/s41591-025-03624-8

Sharifan, A. (2025). Oncolytic Virotherapy in Otorhinolaryngologic Neoplasms: A Scoping Review and Bibliometric Analysis. American Journal of Therapeutics, 10.1097/MJT.0000000000001876: 10.1097/MJT.0000000000001876

Sharifan, A. (2025). Natural Compounds against Mpox: Mapping Evidence and Identifying Gaps. Planta Med, 91: 271-273

Sharifan, A. (2025). Bridging knowledge gaps in phytotherapy for a neglected zoonotic disease: Rift valley fever. Biomedicine & Pharmacotherapy, 187: https://doi.org/10.1016/j.biopha.2025.118092

Sharifan, A.; Abdulazeem, H.; Meckawy, R.; Sonkoue Pianta, M.; Abdelwahab, M.M.; Halder, A.; Gust Duque, T.; (2025). Appraisal of World Health Organization guidelines for priority infectious diseases with potential to cause public health emergencies. Public Health, 240: 112-118

Sofi-Mahmudi, A.; Stojanova, J.; Vounzoulaki, E.; Tomlinson, E.; Pizarro, A.B.; Khademioore, S.; Ngeh, E.; Sharifan, A.; Mrema, L.E.; Britten-Jones, A.C.; Castiello de Obeso, S.; Welch, V.A.; Mbuagbaw, L.; Tugwell, P. (2025). Cochrane reviews’ authorship has become more gender-diverse but remains geographically concentrated: a meta-research study. Journal of Clinical Epidemiology, 181: https://doi.org/10.1016/j.jclinepi.2025.111719

Sharifan, A. (2025). Can smoking cessation interventions initiated during hospitalization help adults admitted for medical or surgical care to quit smoking? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4529: https://doi.org/10.1002/cca.4529

Sharifan, A. (2025). How does continuous infusion compare with bolus injection of furosemide for adults with acute decompensated heart failure? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4455: https://doi.org/10.1002/cca.4455

Sharifan, A. (2025). What are the effects of interventions to improve healthcare professionals' reporting of adverse drug reactions and medication errors? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4537: https://doi.org/10.1002/cca.4537

Sharifan, A. (2025). How does the addition of immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy compare with platinum-based chemotherapy alone as a first-line treatment for older adults with non-small cell lung cancer (NSCLC)? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4509: https://doi.org/10.1002/cca.4509

Sharifan, A. (2025). How does uterine curettage (with or without subsequent adjuvant chemotherapy) compare with primary chemotherapy alone for women with post-molar low-risk, non-metastatic gestational trophoblastic neoplasia? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4514: https://doi.org/10.1002/cca.4514

Sharifan, A. (2025). How do implant-based and autologous tissue-based reconstruction techniques compare for women undergoing breast reconstruction after mastectomy? Cochrane Clinical Answers, https://doi.org/10.1002/cca.4543: https://doi.org/10.1002/cca.4543